Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by FloridaNewfon Aug 28, 2020 1:05pm
219 Views
Post# 31470380

FDA and Nasdaq

FDA and NasdaqBring on that Nasdaq listing and FDA approval. Hopefully we get either or both next week.

Not worried about any other companies tests (the more the merrier), just getting our own FDA approval. We don't have the highest % of the other ones out there, but all of these tests are a little different in detection levels and what they offer (all of which I do not totally understand, so will not try to BS it) . But we have a good, solid, do-it-yourself, early detection test, that seems to have cleared the FDA bar. But we will see soon enough.

Worse case, if it does not, I am sure they will keep working on improving it and resubmit. Not like they will say "Oh well" and chuck all that great work out the door.

But as Sona seems confident enough in the study results to submit, SaudiVax spoke very highly of it and no insider selling showing at all, I'm hanging in there for that 9th inning bases-loaded pitch.

GLTA
Bullboard Posts